Showing results (111-120 of 204) with videos related to

Sort By:
Pageof 21
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 20, 2023
Screening the medicine for malaria venture's Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formationOlabayo H Ajetunmobi, Ashok K Chaturvedi, Hamid Badali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2015
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen TestingP Lewis White, John R Wingard, Stéphane Bretagne, et al.
Medical Mycology|January 30, 2013
Prolyl endopeptidase activity in bronchoalveolar lavage fluid: a novel diagnostic biomarker in a guinea pig model of invasive pulmonary aspergillosisKalyani Jambunathan, Douglas S Watson, Laura K Najvar, et al.
BMC Infectious Diseases|February 25, 2014
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trialJose Vazquez, Annette C Reboli, Peter G Pappas, et al.
Medical Mycology|January 30, 2010
Screening for drug-resistant Candida yeasts with chromogenic agarWilliam R Kirkpatrick, Joseph D Zimmerman, Fadi P Haikal, et al.
Plos One|December 22, 2021
SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe diseaseRaphael A Reyes, Kathleen Clarke, S Jake Gonzales, et al.
Biorxiv : the Preprint Server for Biology|October 6, 2021
SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe diseaseRaphael A Reyes, Kathleen Clarke, S Jake Gonzales, et al.
Antimicrobial Agents and Chemotherapy|September 16, 2015
VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Nathan P Wiederhold, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2014
The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicansNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2017
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Sondus Alkhazraji, Lin Lin, et al.
Pageof 21